FDA Moves to Spur Clinical Trial Options for Patients with Incurable Cancers
- June 25, 2021
The Food and Drug Administration (FDA) issued June 24 draft guidance recommending that patients with incurable cancers be included in cancer clinical trials regardless of whether they have received existing alternative treatment options.
ARTICLE TAGS
You must be logged in to access this content.